Viewing Study NCT04108195


Ignite Creation Date: 2025-12-24 @ 1:40 PM
Ignite Modification Date: 2026-02-27 @ 5:09 PM
Study NCT ID: NCT04108195
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-05
First Post: 2019-09-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple Myeloma
Sponsor: Janssen Research & Development, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module